Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database
Harras B. Zaid(Vanderbilt University Medical Center), Sam S. Chang(Vanderbilt University), Michael S. Cookson(University of Oklahoma Health Sciences Center), Sanjay G. Patel(Vanderbilt University Medical Center), Matthew J. Resnick(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center), C.J. Stimson(Johns Hopkins University)
Cited by 144
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688